“No Hyroxychlorquine and Z-Pack?”
Article states “others were treated with the malaria drug plus the antibiotic azithromycin...”
At some point we’re going to have accept that controlled studies with large groups of patients are the best way to confirm an intervention’s efficacy. Even better if they’re blinded and randomized in their allocation of study subjects. Of course, the timing of administration of HCQ might be critical, and it’s unclear if that was evaluated in this study. The Zinc issue? Who knows?
Yes, the timing of the administration of any medicine or medical device is important, as to the efficacy of their use.
If Hydroxychlorquine is not part of early treatment, which can prevent mounting, snowballing effects of the initial impact of the Wuhan Virus - hpoxia, then yes, ancillary damages due to that initial problem mount and those damages are not directly offset by Hydroxychlorquine, and other interventions are needed, and yes, by then, patients with or without Hydroxychlorquine may do similarly.
But if the patient gets to the doctor in the early stages, and if the doctor puts them on Hyrdroxychlorquine, severe complications can often be avoided.
So yes, in any study the stage of illness with each patient, when Hyrdoxychlorquine is administered must be registered and results categorized by stage of the illness, or it is not a valid study.
So...they gave patients everything...except the one thing that actually stops the virus replicase - zinc.
Without zinc, the studies are worthless, since zinc is what was clinically tested in the original SARS virus, and found to be highly effective.